Loading your page…
Each register with its number of medicines and a few of them.
EMA · 2 medicines
AEMPS · 1 medicine
HALMED · 1 medicine
AIFA · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 1 medicine
FDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
9 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lupkynis | United States | 7.9MG | capsule | Marketed | Aurinia |
| Lupkynis | European Union | Authorised | Otsuka Pharmaceutical Netherlands B.V. | ||
| Lupkynis 7,9 MG Capsulas Blandas | Spain | 7,9 mg | cápsula blanda | Marketed | Otsuka Pharmaceutical Netherlands B.V. |
| Lupkynis | Italy | Capsula molle | Authorised | Otsuka Pharmaceutical Netherlands BV | |
| Lupkynis 7,9 mg, zachte capsules | Netherlands | Capsule, zacht | Authorised | Otsuka Pharmaceutical Netherlands B.V. | |
| Lupkynis | Croatia | Marketed | |||
| Luveniq | European Union | Refused | Lux Biosciences GmbH | ||
| Cyclosporin | Brazil | Cancelled | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Losporin | Brazil | Cancelled | Laboratório Teuto Brasileiro S/A |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, EMA, FDA and HALMED. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
